Haleon Company Description

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.

Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum.

The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Haleon plc

Country	United Kingdom
Founded	1715
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	24,535
CEO	Brian McNamara

Contact Details

Address: The Heights Weybridge United Kingdom
Phone	44 1932 959 500

Stock Details

Ticker Symbol	HLN
Exchange	London Stock Exchange
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BMX86B70
SIC Code	2834

Key Executives

Name	Position
Brian James McNamara	Chief Executive Officer and Executive Director
Dawn Amanda Allen	Chief Financial Officer and Director
Claire Dickson	Chief Digital and Technology Officer
Joanne Russell	Head of Investor Relations
Adrian Charles Morris	General Counsel
Tamara Rogers	Chief Marketing Officer
Line De Decker	Chief Human Resources Officer
Filippo Lanzi	President of EMEA and LatAm
Keith Choy	President of Asia Pacific
Bjorn Timelin	Head of Strategy